Smith+Nephew’s REGENETEN? Bioinductive Implant shows post-operative recovery times halved, and high healing rates for partial-thickness rotator cuff tears1,*
Smith & Nephew SNATS, Inc. (SNN)
Last smith & nephew snats, inc. earnings: 8/1 04:05 pm
Check Earnings Report
US:NYSE Investor Relations:
smithoptics.com
Company Research
Source: GlobeNewswire
Results from the first-ever randomized control trial for the REGENETEN Implant in partial-thickness rotator cuff repair Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces compelling new randomized control trial (RCT) data confirming significant outcome improvements for patients with partial-thickness rotator cuff tears treated with the REGENETEN Bioinductive Implant in isolation.1,* Compared with a traditional suture anchor repair, early recovery time was halved1 for patients returning to daily activities such as: Driving: 2.3 vs 5.1 weeks (p1,**Office work: 1.7 vs 3.6 weeks (p=0.009)1,**Moderate-intensity household chores: 3.8 vs 8.4 weeks (p1,** The study, recently published in the Orthopaedic Journal of Sports Medicine, also concluded that REGENETEN Implant patients enjoyed a better quality of life at 6 weeks and 3 months, and high rates of tendon healing at 1 year, comparable to suture anchor-based repairs.1 This is the third RCT demons
Show less
Read more
Impact Snapshot
Event Time:
SNN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SNN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SNN alerts
High impacting Smith & Nephew SNATS, Inc. news events
Weekly update
A roundup of the hottest topics
SNN
News
- How The Story Is Shifting For S.N. Nuclearelectrica (BVB:SNN) With A Steady RON 49 Target [Yahoo! Finance]Yahoo! Finance
- Smith & Nephew SNATS (SNN) was upgraded by <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=SNN&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall Street Zen</a> from "buy" MarketBeat
- Wound Care Biologics Market Size Projected to Reach USD 6.24 Billion by 2035, Driven by Rising Chronic Wound Burden and Advanced Biologic Therapies – SNS Insider [Yahoo! Finance]Yahoo! Finance
- Smith+Nephew launches next-generation ALLEVYN™ COMPLETE CARE Foam Dressing - designed for high performance in wound management and pressure injury preventionGlobeNewswire
- Neurodegenerative Disease Devices Market to Witness Steady Growth Through 2032, Driven by Advanced Neuromodulation, Says Vyansa Intelligence [Yahoo! Finance]Yahoo! Finance
SNN
Analyst Actions
- 3/5/26 - Canaccord Genuity
SNN
Sec Filings
- 4/16/26 - Form 6-K
- 4/15/26 - Form 6-K
- 4/14/26 - Form 6-K/A
- SNN's page on the SEC website